Emerald Mutual Fund Advisers Trust’s Applied Therapeutics APLT Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-631,922	Closed	-$5.66M	–	212
2021 Q4	$5.66M	Buy	631,922 +10,605	+2%	+$139K	0.2%	123
2021 Q3	$10.3M	Sell	621,317 -31,539	-5%	-$545K	0.36%	89
2021 Q2	$13.6M	Buy	652,856 +8,284	+1%	+$157K	0.44%	91
2021 Q1	$12.1M	Buy	644,572 +104,932	+19%	+$2.26M	0.4%	95
2020 Q4	$11.9M	Buy	539,640 +36,140	+7%	+$752K	0.41%	94
2020 Q3	$10.5M	Buy	503,500 +150,522	+43%	+$3.91M	0.46%	74
2020 Q2	$12.8M	Buy	352,978 +65,767	+23%	+$2.75M	0.6%	61
2020 Q1	$9.39M	Sell	287,211 -345,539	-55%	-$14M	0.59%	62
2019 Q4	$17.3M	Buy	632,750 +100,488	+19%	+$1.72M	0.71%	49
2019 Q3	$5.85M	Buy	532,262 +71,282	+15%	+$673K	0.26%	118
2019 Q2	$3.8M	Buy	+460,980	New	+$4.36M	0.15%	152

Other funds holding APLT

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's APLT Position: Q1 2022 in Review

Emerald Mutual Fund Advisers Trust sold out of Applied Therapeutics (APLT) in Q1 2022, closing a stake of 631,922 shares — an estimated $5.66M sold.

Emerald Mutual Fund Advisers Trust first reported a position in APLT in Q2 2019 and held it in 11 quarters. The position peaked at $17.3M in Q4 2019. 71 funds tracked by Wall St. Rank hold APLT as of Q1 2022.

Emerald Mutual Fund Advisers Trust reported no remaining Applied Therapeutics position as of Q1 2022 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 631,922 Applied Therapeutics shares in Q1 2022, an estimated $5.66M.
Emerald Mutual Fund Advisers Trust first reported a position in Applied Therapeutics in Q2 2019 and held it in 11 quarters.
Emerald Mutual Fund Advisers Trust's Applied Therapeutics position peaked at $17.3M in Q4 2019.
71 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2022.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2022, filed 29 Apr 2022.